Showing results (1461-1470 of 6,735) with videos related to
Sort By:
Pageof 674
Journal of Clinical Epidemiology|June 28, 2025
Clinical study report data did not substantially alter point estimates but improved precision in a nephrology systematic reviewJulian Hirt, Dawid Pieper, Monika Becker, et al.Journal of Clinical Epidemiology|December 21, 2025
The use of guidelines in multimorbidity related practice: An exploratory questionnaire surveyZijun Wang, Hongfeng He, Sergey K Zyryanov, et al.Journal of Clinical Epidemiology|December 29, 2025
An imputation study shows that missing outcome data can substantially bias pooled estimates in systematic reviews of patient-reported outcomesYanjiao Shen, Zhengchi Li, Xianlin Gu, et al.Journal of Clinical Epidemiology|December 29, 2025
SYSTEMATIC REVIEWS OF QUASI-EXPERIMENTAL STUDIES: CHALLENGES AND CONSIDERATIONSSarah B Windle, Sam Harper, Jasleen Arneja, et al.Journal of Clinical Epidemiology|December 29, 2025
Defining Survival Epidemiology: Postdiagnosis Population Science for People Living with DiseaseRaphael E CuomoJournal of Clinical Epidemiology|December 14, 2025
Defining racial health equity: an integrative analysis of terminology and conceptualizationsElizabeth A Terhune, Mahederemariam Bayleyegn Dagne, Miriam Barsoum, et al.Journal of Clinical Epidemiology|December 6, 2025
Comparison between risk of bias-1 and risk of bias-2 tool and impact on network meta-analysis results-A case study from a living Cochrane review on psoriasisR Guelimi, C Choudhary, C Ollivier, et al.Journal of Clinical Epidemiology|February 13, 2025
Cochrane reviews' authorship has become more gender-diverse but remains geographically concentrated: a meta-research studyAhmad Sofi-Mahmudi, Jana Stojanova, Elpida Vounzoulaki, et al.Journal of Clinical Epidemiology|February 17, 2025
Review of the quality of reporting of statistical analysis plans for cluster randomized trialsJacqueline Y Thompson, Julia Shaw, Samuel I Watson, et al.Journal of Clinical Epidemiology|February 6, 2025
Income inequality and access to advanced immunotherapy for lung cancer: the case of Durvalumab in the NetherlandsDimitris Katsimpokis, Mieke J Aarts, Gijs Geleijnse, et al.Pageof 674